MRK
Merck & Co., Inc. Shs Cert Deposito Arg Repr 1/5 Sh · BCBA:MRK
49,380.00 ARS−220.00 −0.44%
Merck & Co., Inc. Shs Cert Deposito Arg Repr 1/5 Sh (BCBA:MRK) last traded at 49,380.00 ARS, down 0.44% on the day. Over the past year the stock is up 92.89%. Its 52-week range is 25,000.00 to 50,600.00. It is in the Health Technology sector (Pharmaceuticals: Major).
Key statistics
Open49,600.00
Day range48,840.00 – 49,680.00
52-week range25,000.00 – 50,600.00
Volume6.20 K
Average volume (10 days)4.16 K
Market cap (USD)368.89 B
P/E155.93
EPS (TTM) (USD)0.2074
Dividend yield1.30%
Beta (1 year)−0.1393
Revenue (TTM) (USD)63.48 B
Employees75.00 K
Performance
+1.77%1 week
+6.47%1 month
+21.33%3 months
+46.27%6 months
+51.47%Year to date
+92.89%1 year
Technical reading
Strongly bullish
Daily summary of what 11 oscillators and 15 moving averages show. See every indicator
Latest headlines
- Merck Stocks Decline With Higher Target Leaving a New-Launch Scale TestGuruFocus · 02 Nov 2026
- Merck Is Maintained at Neutral by Cantor FitzgeraldDow Jones Newswires · 02 Nov 2026
- Merck to Present New Data from Its Broad Oral HIV Portfolio and Pipeline at HIV Glasgow 2026BusinessWire · 02 Nov 2026
- From Near Miss To Crown Jewel: The Rise, Reign And Road Ahead For Merck's Keytrudadpa-AFX · 01 Nov 2026
- Notable healthcare headlines for the week: Eli Lilly, Merck, and AstraZeneca in focusSeeking Alpha · 01 Nov 2026
- Merck Price Target Raised to $175.00/Share From $165.00 by JP MorganDow Jones Newswires · 30 Oct 2026
- Merck Stocks Rise 2.6% With Qlex Still Under 10% of Keytruda SalesGuruFocus · 30 Oct 2026
- Merck One of Top Large-Cap Biopharma Picks-AnalystBenzinga · 30 Oct 2026
Market data is delayed as each exchange requires (see data coverage). SuperCharting is charting software and gives no investment advice.